Carlyle to acquire Unchained Labs for $435mn

Exiting investors in the life sciences tools company are Novo Holdings A/S, Canaan Partners and TPG Biotech. 

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this